학술논문
Hepatocyte Growth Factor Receptor overexpression predicts reduced survival but its targeting is not effective in unselected HNSCC patients.
Document Type
Article
Author
Source
Head & Neck; Apr2020, Vol. 42 Issue 4, p625-635, 11p
Subject
Language
ISSN
10433074
Abstract
Copyright of Head & Neck is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)